Methoxyphenyl maleamic acid augments the activity of cytotoxic drugs against murine tumours.
Indian J Cancer
;
1991 Mar; 28(1): 22-6
Article
Dans Anglais
| IMSEAR
| ID: sea-49320
ABSTRACT
The anti-tumour effects of methoxyphenyl maleamic acid (MPMA) and cytotoxic drugs, in combination were investigated on P388 leukaemia and S180 (ascites) tumours. Simultaneous administration of MPMA with CTX or HN2 resulted in enhancement of anti-tumour activity. The increased activity was observed against P388 leukaemia, whereas S180 (ascites) tumour was not responsive to the combined treatment. The possible mechanism (s) of action, responsible for the modulation of activity of CTX and HN2 against P388 tumour have been postulated.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Ascites
/
Leucémie P388
/
Protocoles de polychimiothérapie antinéoplasique
/
Cyclophosphamide
/
Synergie des médicaments
/
Animaux
/
Maléates
/
Chlorméthine
/
Souris
langue:
Anglais
Texte intégral:
Indian J Cancer
Année:
1991
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS